Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1984-2-14
|
pubmed:abstractText |
A double-blind clinical comparison of cefadroxil granules (CDX) and a long-acting preparation of cephalexin granules (L-CEX) was conducted in the treatment of impetigo in children. The long-acting cephalexin preparation was composed of 3 parts of granules soluble in the stomach and 7 parts of those soluble in the intestine. Drugs were administered at 3 different doses depending on the body weight of patients (Group I: less than 10 kg, Group II: between 10 kg and 20 kg, Group III: over 20 kg). Overall clinical evaluation by attending doctors: CDX group scored slightly better but not statistically significant results. Evaluation of usefulness: CDX group scored slightly better but not statistically significant results. Partially standardized evaluation: CDX scored statistically significantly higher points in the evaluation of total cases and Group II on Day 5, and Group II on Day 7. Cumulative points through Day 5 and Day 7 were not statistically significant. Follow-up evaluation by attending doctors: CDX group got a better result in total cases and Group II on day 3, and in total cases on days 5 and 7. Otherwise there was no statistically significant difference. Incidence of side effects was not significantly different between the 2 drug groups. As shown in Fig. 1, CDX was administered on rising in the morning, after lunch, and at bed time whereas L-CEX was given on rising and at bed time when the patients were relatively in fasting condition. This may have reduced the expected merit of L-CEX and some reserve is required in the interpretations of the results shown herein.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0368-2781
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
1443-60
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:6361311-Adolescent,
pubmed-meshheading:6361311-Cefadroxil,
pubmed-meshheading:6361311-Cephalexin,
pubmed-meshheading:6361311-Child,
pubmed-meshheading:6361311-Child, Preschool,
pubmed-meshheading:6361311-Clinical Trials as Topic,
pubmed-meshheading:6361311-Delayed-Action Preparations,
pubmed-meshheading:6361311-Double-Blind Method,
pubmed-meshheading:6361311-Drug Administration Schedule,
pubmed-meshheading:6361311-Female,
pubmed-meshheading:6361311-Humans,
pubmed-meshheading:6361311-Impetigo,
pubmed-meshheading:6361311-Infant,
pubmed-meshheading:6361311-Male,
pubmed-meshheading:6361311-Staphylococcus aureus
|
pubmed:year |
1983
|
pubmed:articleTitle |
[Double-blind comparison of cefadroxil and cephalexin granules in the treatment of impetigo].
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
English Abstract,
Controlled Clinical Trial
|